2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Highlights on Recurred/Metastatic ACC: Does Axitinib Increase PFS Rate Compared to Observation? How Does Tipifarnib Affect H&N Tumors With HRAS Mutations?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Michael Gibson
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Michael Gibson
14 views
September 29, 2020
Comments 0
Login to view comments.
Click here to Login
Head&Neck
